Telehealth in Family Medicine
Telehealth has reshaped how family medicine physicians deliver care by enabling clinical encounters, chronic disease monitoring, and behavioral health support without requiring in-person presence. This page covers the definition and regulatory scope of telehealth in family medicine, the technical and clinical mechanisms that underpin it, the conditions and scenarios where it is most commonly applied, and the decision boundaries that determine when in-person care is necessary. Understanding these distinctions matters because telehealth reimbursement, licensure requirements, and clinical appropriateness are all governed by overlapping federal and state frameworks.
Definition and scope
Telehealth in family medicine refers to the delivery of health-related services and information via electronic information and telecommunication technologies. The Health Resources and Services Administration (HRSA) distinguishes telehealth broadly from the narrower term telemedicine, with telemedicine referring specifically to remote clinical services, while telehealth also encompasses provider training, administrative meetings, and patient education delivered electronically.
Within family medicine, telehealth spans four primary modalities recognized by the Centers for Medicare & Medicaid Services (CMS):
- Synchronous video visits — real-time audiovisual encounters between patient and clinician
- Telephone-only encounters — audio-only visits, subject to separate billing rules under Medicare
- Asynchronous (store-and-forward) — transmission of recorded health data, images, or patient-reported information reviewed by a clinician at a later time
- Remote Patient Monitoring (RPM) — continuous or periodic collection of physiologic data (blood pressure, glucose, weight) via connected devices, transmitted to the care team
The regulatory landscape for telehealth intersects with the broader framework described at /regulatory-context-for-family-medicine, including Medicare conditions of participation, HIPAA requirements, and state medical practice acts. As of 2023, CMS telehealth coverage for Medicare beneficiaries was governed under expansions originally authorized by the Consolidated Appropriations Act of 2023 (CMS Telehealth Services Fact Sheet).
How it works
A telehealth encounter in family medicine follows a structured clinical workflow that mirrors in-person visits in key respects while introducing distinct technical and regulatory requirements.
The core process involves five phases:
-
Scheduling and consent — The patient schedules a telehealth appointment through a patient portal, phone, or app. Informed consent for telehealth is required in most states and must be documented in the medical record, per guidance from the American Academy of Family Physicians (AAFP).
-
Technology verification — The physician's practice must use a platform compliant with HIPAA's Security Rule (45 CFR Part 164). CMS temporarily permitted use of non-HIPAA-compliant platforms during the COVID-19 public health emergency, but standard practice requires encrypted, access-controlled video tools.
-
Clinical encounter — The physician conducts the history, reviews available data (labs, vitals from RPM, prior records), and performs whatever limited physical assessment is feasible. A 2022 AAFP survey found that 83 percent of family physicians reported using telehealth in their practice, up from under 20 percent before 2020 (AAFP 2022 Practice Profile).
-
Documentation — The encounter is documented in the EHR following standard evaluation and management (E/M) coding guidelines. CMS billing for synchronous telehealth uses Place of Service code 02 (telehealth other than patient's home) or 10 (patient's home).
-
Prescribing and follow-up — Prescriptions, referrals, or lab orders are issued electronically. Controlled substance prescribing via telehealth is subject to the Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. § 829) and DEA regulations, which historically required at least one in-person encounter before prescribing Schedule II–V substances via telemedicine, though DEA proposed rule modifications in 2023.
Common scenarios
Telehealth is not uniformly applicable across all family medicine services. The following conditions and encounter types have the strongest evidence base and policy support for telehealth delivery:
- Chronic disease management — Hypertension, type 2 diabetes, hyperlipidemia, and asthma follow-up visits fit well within telehealth workflows, particularly when combined with RPM data. Structured chronic disease management through /chronic-disease-management-family-medicine relies on longitudinal data review that telehealth supports effectively.
- Behavioral health and mental health — Depression screening, anxiety follow-up, medication management for psychiatric conditions, and counseling referrals are among the highest-volume telehealth use cases in primary care. Medicare covers behavioral health services delivered via telehealth under the Mental Health Access Improvement Act provisions included in the Consolidated Appropriations Act of 2023.
- Medication management — Review of stable medications, side effect assessment, and adherence counseling for non-controlled substances.
- Minor acute complaints — Upper respiratory infections, urinary tract infection symptom assessment, rash evaluation (using store-and-forward or video), and conjunctivitis.
- Preventive care coordination — Cancer screening reminders, immunization counseling, and wellness planning that does not require physical examination. This connects to the preventive services scope covered at /index.
- Post-discharge follow-up — Short-interval telehealth check-ins following hospital discharge are associated with reduced readmission rates in published literature.
- Pediatric and geriatric check-ins — Developmental milestone review for pediatric patients and functional status monitoring for older adults, when physical examination is not the primary objective.
Decision boundaries
Not all clinical needs are appropriate for telehealth delivery. Family medicine physicians apply a structured set of clinical and regulatory criteria to determine when an in-person encounter is required.
Telehealth is generally not appropriate when:
- Physical examination findings are essential to diagnosis (suspected appendicitis, joint effusion, cardiac murmur evaluation, abdominal mass assessment)
- The patient requires in-office procedures such as wound care, joint injection, Pap smear, or immunization administration — categories covered under /minor-procedures-in-family-medicine
- Imaging or laboratory collection must occur on-site
- The patient's condition is emergent and requires immediate intervention
- Technology access is unavailable — approximately 21 million Americans lacked fixed broadband access as of 2021 (FCC Broadband Deployment Report 2021), creating a documented equity gap
Telehealth vs. in-person: a structural comparison
| Factor | Telehealth | In-Person |
|---|---|---|
| Physical exam capability | Limited (visual only, patient self-report) | Full clinical exam |
| Geographic access | High — eliminates travel barrier | Requires patient transport |
| Controlled substance prescribing | Restricted under DEA Ryan Haight Act | No additional restriction |
| HIPAA compliance requirement | Required (45 CFR Part 164) | Required |
| Billing modifiers required | Yes (POS 02 or 10, modifier 95 or GT) | Standard E/M codes |
| RPM integration | High compatibility | Lower integration in real-time |
The Office for Civil Rights (OCR) at HHS maintains specific guidance on HIPAA compliance for telehealth technologies, which family medicine practices must apply when selecting platforms and configuring access controls.
State licensure presents an additional boundary: a physician must generally hold a medical license in the state where the patient is physically located at the time of the encounter. The Interstate Medical Licensure Compact (IMLC), administered by the IMLC Commission, allows expedited licensure in 37 participating states as of 2023, reducing but not eliminating this barrier for multi-state telehealth practice.
References
- Health Resources and Services Administration (HRSA) — Telehealth
- Centers for Medicare & Medicaid Services (CMS) — Medicare Telehealth
- American Academy of Family Physicians (AAFP) — Telehealth
- HHS Office for Civil Rights — HIPAA and Telehealth
- Federal Communications Commission — 2021 Broadband Deployment Report
- Interstate Medical Licensure Compact (IMLC)
- Ryan Haight Online Pharmacy Consumer Protection Act, 21 U.S.C. § 829
- Consolidated Appropriations Act of 2023 — CMS Telehealth Extensions
The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)